European Union legislation national procedure

Pharmaceutical regulation in the United Kingdom (UIQ has, since accession in 1973 to the European Union (EU), followed the requirements of the many directives that have been agreed in this field. Most of the pharmaceutical legislation now introduced in the UK emanates from the EU. Nevertheless, some specifically national laws still apply, and many national practices and procedures which have evolved over the yeeu s are specific to the UK. This chapter is intended to provide an overview of those key national requirements which are of particular relevcince to the pharmaceutical industry. The author has had personal experience of many of the practices, procedures, and regulations discussed nevertheless the reader is advised to consult the official texts and if necessary seek specific advice in the interpretation of current requirements. 

Workplace risk assessment can be defined as a systematic procedure for analysing workplace components to identify and evaluate hazards and safety characteristics (Harms-Ringdahl 2001). Due to EU regulation (Council Directive 89/391/EEC) each member state of the European Union has to establish national legislation to demand risk assessment procedures in enterprises of all sizes. In Estonia, the Act on Occupational Health and Safety that requires risk assessment at the every workplace was adopted in 1999. Workplace risk assessment has to be conducted by the employers using their own resources or by registered practitioners in occupational health (Occupational Health and Safety Act 1999). 

---